Last 46 quarters of trend data · Healthcare · Healthcare Providers
Quarterly valuation ratios — annualised for comparability. YoY Δ shows same-quarter-prior-year change.
| Metric | TTM | Q2 '26 | Q1 '26 | Q4 '25 | Q3 '25 | Q2 '25 | Q1 '25 | Q4 '24 | Q3 '24 | Q2 '24 | Q1 '24 | Q4 '23 | Q3 '23 | Q2 '23 | Q1 '23 | Q4 '22 | Q3 '22 | Q2 '22 | Q1 '22 | Q4 '21 | Q3 '21 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| P/E Ratio → | -33.73 | — | — | — | — | — | — | — | — | — | — | — | 25.22 | 74.98 | 897.66 | 30.28 | — | 42.53 | 29.28 | — | — |
| — | — | — | — | — | — | — | — | — | — | — | — | — | +76.3% | +2965.6% | — | — | — | — | — | — | |
| P/S Ratio | 0.90 | 0.64 | 0.47 | 0.56 | 0.84 | 0.85 | 0.97 | 0.77 | 1.32 | 0.98 | 1.31 | 1.37 | 1.36 | 2.15 | 1.62 | 1.00 | 0.84 | 1.04 | 2.08 | 1.85 | 1.53 |
| — | -25.4% | -51.3% | -28.2% | -36.7% | -13.2% | -26.0% | -43.5% | -3.2% | -54.1% | -19.1% | +36.3% | +62.8% | +105.5% | -22.3% | -45.7% | -45.2% | -50.8% | +76.2% | +186.0% | +183.2% | |
| P/B Ratio | 0.84 | 0.70 | 0.44 | 0.56 | 0.77 | 0.79 | 0.84 | 0.73 | 1.15 | 0.83 | 1.12 | 1.20 | 1.11 | 1.73 | 1.31 | 0.86 | 0.85 | 1.08 | 2.11 | 1.96 | 1.84 |
| — | -11.5% | -47.6% | -24.2% | -32.6% | -4.9% | -25.0% | -38.6% | +3.4% | -52.1% | -14.8% | +38.4% | +30.2% | +60.4% | -37.8% | -56.0% | -53.6% | -57.0% | +61.4% | +124.7% | +162.2% | |
| P/FCF | 16.17 | 14.43 | — | 5.42 | 10.76 | 12.19 | — | 7.50 | 22.60 | 13.42 | 47.69 | 23.50 | 10.73 | 54.47 | 21.49 | — | 41.94 | 32.63 | 20.17 | 201.53 | — |
| — | +18.4% | — | -27.7% | -52.4% | -9.2% | — | -68.1% | +110.6% | -75.4% | +121.9% | — | -74.4% | +67.0% | +6.6% | — | — | — | +18.8% | — | — | |
| EV / EBITDA | 11.81 | 10.55 | 11.12 | 8.45 | 11.04 | 10.61 | 16.94 | 9.48 | 16.57 | 12.99 | 15.34 | 13.00 | 14.45 | 17.32 | 21.76 | 11.08 | 13.22 | 13.73 | 15.63 | 13.49 | 17.72 |
| — | -0.6% | -34.4% | -10.9% | -33.4% | -18.3% | +10.4% | -27.1% | +14.7% | -25.0% | -29.5% | +17.3% | +9.3% | +26.2% | +39.2% | -17.9% | -25.4% | -36.8% | +11.0% | +52.9% | -21.6% | |
| EV / EBIT | 17.51 | 14.61 | 20.00 | 6.11 | 4.38 | 14.44 | 26.87 | 12.01 | 30.24 | 18.33 | 22.14 | 16.99 | 19.50 | 21.65 | 37.56 | 14.56 | 18.54 | 18.75 | 19.90 | 16.16 | 24.74 |
| — | +1.2% | -25.6% | -49.1% | -85.5% | -21.2% | +21.3% | -29.3% | +55.0% | -15.4% | -41.0% | +16.7% | +5.2% | +15.5% | +88.8% | -9.9% | -25.1% | -39.3% | +1.0% | +44.8% | -52.5% |
Quarterly margins and returns. Watch for margin compression across consecutive quarters.
| Metric | TTM | Q2 '26 | Q1 '26 | Q4 '25 | Q3 '25 | Q2 '25 | Q1 '25 | Q4 '24 | Q3 '24 | Q2 '24 | Q1 '24 | Q4 '23 | Q3 '23 | Q2 '23 | Q1 '23 | Q4 '22 | Q3 '22 | Q2 '22 | Q1 '22 | Q4 '21 | Q3 '21 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Gross Margin | 23.1% | 22.4% | 15.0% | 24.0% | 23.8% | 23.7% | 20.9% | 27.0% | 23.0% | 23.5% | 21.6% | 26.3% | 24.6% | 23.1% | 20.1% | 26.1% | 21.1% | 21.9% | 20.9% | 24.1% | 21.9% |
| — | -5.4% | -28.1% | -11.3% | +3.2% | +0.7% | -3.6% | +2.7% | -6.3% | +1.9% | +7.6% | +1.0% | +16.3% | +5.5% | -3.9% | +8.1% | -3.5% | +0.4% | +3.6% | -2.4% | -4.8% | |
| Operating Margin | 11.8% | 12.0% | 10.2% | 12.5% | 12.9% | 13.5% | 8.0% | 14.7% | 7.9% | 11.1% | 10.6% | 13.8% | 12.3% | 14.6% | 7.0% | 13.3% | 11.9% | 12.4% | 16.8% | 18.8% | 11.4% |
| — | -11.0% | +27.4% | -15.3% | +62.8% | +21.5% | -24.7% | +6.6% | -35.5% | -23.9% | +52.1% | +3.5% | +2.6% | +17.6% | -58.6% | -29.2% | +5.0% | +13.5% | +34.2% | +7.1% | +205.0% | |
| Net Margin | -2.4% | -1.8% | -4.4% | -1.7% | -2.8% | -0.3% | -4.9% | -12.6% | -4.1% | -2.0% | -1.7% | -0.1% | -0.7% | 2.8% | -3.7% | -3.3% | -4.0% | -3.0% | 2.0% | -0.0% | -4.1% |
| — | -483.9% | +8.9% | +86.5% | +32.8% | +85.1% | -181.1% | -9129.5% | -466.1% | -171.8% | +53.8% | +95.9% | +82.0% | +194.7% | -282.7% | -20078.7% | +1.6% | +39.6% | +149.9% | -101.6% | +67.0% |
| Metric | TTM | Q2 '26 | Q1 '26 | Q4 '25 | Q3 '25 | Q2 '25 | Q1 '25 | Q4 '24 | Q3 '24 | Q2 '24 | Q1 '24 | Q4 '23 | Q3 '23 | Q2 '23 | Q1 '23 | Q4 '22 | Q3 '22 | Q2 '22 | Q1 '22 | Q4 '21 | Q3 '21 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| ROE | -2.2% | -0.5% | -1.0% | -0.4% | -0.6% | -0.1% | -1.0% | -3.0% | -0.9% | -0.4% | -0.4% | -0.0% | -0.1% | 0.6% | -0.8% | -0.8% | -1.0% | -0.8% | 0.5% | -0.0% | -1.2% |
| — | -552.9% | +1.9% | +86.0% | +28.0% | +84.3% | -183.0% | -10003.0% | -498.5% | -177.5% | +51.3% | +96.3% | +85.7% | +173.7% | -244.6% | -16925.0% | +16.3% | +46.7% | +143.4% | -101.4% | +68.3% | |
| ROA | -1.0% | -0.2% | -0.4% | -0.2% | -0.3% | -0.0% | -0.5% | -1.4% | -0.4% | -0.2% | -0.2% | -0.0% | -0.1% | 0.3% | -0.4% | -0.4% | -0.4% | -0.3% | 0.2% | -0.0% | -0.4% |
| — | -493.6% | +7.4% | +86.8% | +32.3% | +85.3% | -165.9% | -9536.3% | -477.3% | -175.2% | +52.1% | +95.9% | +81.2% | +197.4% | -290.0% | -20723.5% | +4.2% | +38.8% | +151.8% | -101.7% | +65.1% | |
| ROIC | 4.1% | 1.1% | 0.8% | 1.1% | 1.1% | 1.2% | 0.6% | 1.4% | 0.7% | 1.0% | 0.9% | 1.2% | 1.0% | 1.2% | 0.6% | 1.2% | 1.0% | 1.1% | 1.4% | 1.7% | 1.0% |
| — | -7.2% | +30.1% | -17.0% | +64.6% | +20.1% | -28.5% | +10.9% | -34.7% | -21.0% | +54.8% | +3.1% | +4.9% | +16.4% | -58.8% | -30.8% | -4.8% | +6.8% | +32.8% | +5.7% | +221.0% |
Quarterly solvency trend — watch for debt spikes or covenant pressure.
| Metric | TTM | Q2 '26 | Q1 '26 | Q4 '25 | Q3 '25 | Q2 '25 | Q1 '25 | Q4 '24 | Q3 '24 | Q2 '24 | Q1 '24 | Q4 '23 | Q3 '23 | Q2 '23 | Q1 '23 | Q4 '22 | Q3 '22 | Q2 '22 | Q1 '22 | Q4 '21 | Q3 '21 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Debt / Equity | 1.14 | 1.30 | 1.16 | 1.14 | 1.09 | 1.08 | 1.08 | 1.02 | 0.99 | 0.95 | 0.94 | 0.91 | 0.90 | 0.88 | 0.88 | 0.89 | 1.46 | 1.43 | 1.44 | 1.43 | 1.72 |
| — | +19.5% | +7.1% | +12.0% | +9.9% | +14.4% | +15.0% | +11.9% | +9.6% | +8.2% | +6.5% | +2.0% | -38.1% | -38.5% | -38.9% | -37.7% | -15.2% | -18.2% | -16.0% | -27.3% | -18.5% | |
| Debt / EBITDA | 7.12 | 28.41 | 33.32 | 23.66 | 26.66 | 25.52 | 39.46 | 23.00 | 31.68 | 28.67 | 28.80 | 23.11 | 26.93 | 23.77 | 36.21 | 23.66 | 34.36 | 32.49 | 26.61 | 23.96 | 36.10 |
| — | +11.3% | -15.6% | +2.9% | -15.8% | -11.0% | +37.0% | -0.4% | +17.6% | +20.6% | -20.5% | -2.4% | -21.6% | -26.8% | +36.1% | -1.2% | -4.8% | -14.2% | -24.8% | -8.7% | -52.4% | |
| Current Ratio | 1.87 | 1.95 | 1.86 | 1.87 | 1.88 | 1.93 | 1.89 | 1.79 | 1.80 | 1.83 | 1.71 | 1.71 | 1.75 | 1.77 | 1.83 | 1.87 | 1.18 | 1.51 | 1.73 | 1.76 | 1.56 |
| — | +1.0% | -1.4% | +4.3% | +4.4% | +5.1% | +10.3% | +4.8% | +3.0% | +3.9% | -6.4% | -8.3% | +47.8% | +16.9% | +5.8% | +5.9% | -24.1% | -15.6% | -2.4% | +22.4% | +3.0% | |
| Quick Ratio | 1.71 | 1.78 | 1.69 | 1.71 | 1.72 | 1.78 | 1.73 | 1.65 | 1.66 | 1.69 | 1.56 | 1.57 | 1.61 | 1.61 | 1.68 | 1.72 | 1.07 | 1.39 | 1.61 | 1.65 | 1.45 |
| — | -0.0% | -2.6% | +3.7% | +3.9% | +5.2% | +10.7% | +5.3% | +3.1% | +4.6% | -6.7% | -9.0% | +50.0% | +16.2% | +4.1% | +4.4% | -25.9% | -17.5% | -3.7% | +23.2% | +1.5% | |
| Interest Coverage | 1.43 | 1.46 | 0.95 | 1.22 | 1.09 | 1.65 | 1.00 | 2.40 | 1.22 | 1.65 | 1.61 | 2.08 | 1.66 | 2.05 | 0.99 | 1.54 | 1.22 | 1.34 | 1.78 | 1.91 | 1.17 |
| — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
Includes 30+ ratios · 46 years · Updated daily
Live VCP patterns, Cup & Handle overlays, support/resistance, and AI trade plans.
High-probability breakout stocks crossing their pivot across 5 pattern engines.
DCF models, multiple analysis, and analyst estimates.
10-year return with dividends reinvested.
Compare growth, multiples, and margins vs sector.
Quick answers to the most common questions about buying SGRY stock.
Surgery Partners, Inc.'s current P/E is -33.7x. Quarterly P/E ratios can vary due to seasonal revenue patterns and one-time charges.
Surgery Partners, Inc.'s current operating margin is 11.8%. Margins have been compressing over recent quarters. Quarterly margins are particularly useful for identifying trend inflections that annual data smooths over.
Quarterly financial ratios reveal short-term trend shifts — margin compression, debt spikes, or valuation re-ratings — that annual figures smooth over. They're essential for active investors tracking Surgery Partners, Inc.'s business trajectory between earnings reports.